TET2 and hepatocellular carcinoma: Considering that vitamin C has been utilized for a clinical trial (33), our study not only provokes clear biomarkers and molecular mechanism on the basis of TET2–KMT2D axis, but also proposes an alternative strategy for management of HCC.